title: MAGfect: a novel liposome formulation for MRI labelling and visualization of cells.
abstract: Cellular entry of imaging probes, such as contrast agents for magnetic resonance imaging (MRI), is a key requirement for many molecular imaging studies, particularly imaging intracellular events and cell tracking. Here, we describe the successful development and in vitro analysis of MAGfect, a novel liposome formulation containing a lipidic gadolinium contrast agent for MRI, Gd-DOTA-Chol , designed to enter and label cells. Liposome formulation and cell incubation time were optimised for maximum cellular uptake of the imaging probe in a variety of cell lines. MRI analysis of cells incubated with MAGfect showed them to be highly MRI active. This formulation was examined further for cytotoxicity, cell viability and mechanism of cell labelling. One of the key advantages of using MAGfect as a labelling vehicle arises from its potential for additional functions, such as concomitant drug or gene delivery and fluorescent labelling. The gadolinium liposome was found to be an effective vehicle for transport of plasmid DNA (pDNA) into cells and expression levels were comparable to the commercial transfection agent Trojene.
authors.affiliation: Imperial College Genetic Therapies Centre, Department of Chemistry, Flowers Building, Armstrong Road, Imperial College London, Hammersmith Hospital, London, UK SW7 2AZ.
authors.forename: Morag
authors.initials: M
authors.lastname: Oliver
authors.forename: Ayesha
authors.initials: A
authors.lastname: Ahmad
authors.forename: Nazila
authors.initials: N
authors.lastname: Kamaly
authors.forename: Eric
authors.initials: E
authors.lastname: Perouzel
authors.forename: Annabelle
authors.initials: A
authors.lastname: Caussin
authors.forename: Michael
authors.initials: M
authors.lastname: Keller
authors.forename: Amy
authors.initials: A
authors.lastname: Herlihy
authors.forename: Jimmy
authors.initials: J
authors.lastname: Bell
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Miller
authors.forename: Michael R
authors.initials: MR
authors.lastname: Jorgensen
mesh_terms: D002477:Cells / Q000737:chemistry* / Q000187:drug effects; D004247:DNA / Q000378:metabolism; D005682:Gadolinium / Q000378:metabolism; D006367:HeLa Cells; D006571:Heterocyclic Compounds / Q000737:chemistry; D006801:Humans; D008055:Lipids; D008081:Liposomes / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D009942:Organometallic Compounds / Q000737:chemistry; D010957:Plasmids / Q000378:metabolism; D013194:Staining and Labeling / Q000379:methods*; D014162:Transfection
chemical_list: D006571:Heterocyclic Compounds; D008055:Lipids; D008081:Liposomes; D009942:Organometallic Compounds; D004247:DNA; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; D005682:Gadolinium